Global launch of new Biosen C-Line glucose and Lactate analyzer

EKF Diagnostics Holdings plc, the AIM-listed global diagnostics business, announces the launch of its new Biosen C-Line, an advanced version of its industry leading rapid benchtop glucose and lactate analyzer. The new and updated analyzer has been designed to enhance usability with the latest colour, touch screen and advanced connectivity, enabling the Biosen C-Line to seamlessly connect with hospital and laboratory IT systems, via EKF Link, to ensure patient results are quickly and securely available to clinicians. The Biosen C-Line analyzer measures glucose and lactate levels in whole blood, plasma and serum, using enzymatic sensor technology to give highly precise results, less than 3% CV. It is used by clinical professionals in both primary and secondary care settings around the world to provide fast and accurate glucose analysis for the detection and management of diabetes, a chronic condition which is expected to affect 1.31 billion people worldwide by 2050.